top of page

Topic

Surgical Oncology

33 Podcasts • 6 Cases • 6 Courses on BackTable

Hear how experienced clinicians in Surgical Oncology approach day-to-day decision-making on BackTable. Learn from podcasts, cases, and courses curated by physician content creators. Get the BackTable app to follow this Topic and hear more of the conversations that matter to your practice.

Techniques & Outcomes of Portal Vein Embolization
00:00 / 01:04

Save your progress. Continue watching on the BackTable app.

BackTable Vascular & Interventional

Episode # 660  •  03 Jul 2026

Techniques & Outcomes of Portal Vein Embolization

How is portal vein embolization (PVE) pushing the boundaries of liver tumor resectability, and what does it take to induce hypertrophy without compromising the remnant liver? In this episode of the BackTable Podcast, interventional radiologist Dr. David Madoff of Yale University joins Dr. Michael Barraza to discuss the pathophysiological rationale, technical considerations, and emerging clinical paradigms of performing PVE to augment the future liver remnant (FLR) prior to resection and reduce the risk of postoperative liver failure.

This podcast is supported by

RADPAD® Radiation Protection

More on Surgical Oncology

Loading recent podcasts…

VI

Vascular & IR # 660

Jul 3, 2026

with Dr. David Madoff, Dr. Michael Barraza

Techniques & Outcomes of Portal Vein Embolization

How is portal vein embolization (PVE) pushing the boundaries of liver tumor resectability, and what does it take to...

Tumor Board

Tumor Board # 67

Jun 18, 2026

with Dr. Sunil Patel, Dr. Kristen Scarpato, Dr. Bogdana Schmidt

Bladder Cancer Risk Stratification: Best Practices

Why does up to 10% of bladder cancer pathology change on expert review, and what does that mean for your intermediate...

30+ listens

VI

Vascular & IR # 655

Jun 16, 2026

with Dr. Tyler Sandow, Dr. Beau Toskich, Dr. Christopher Malone, Dr. Zach Berman

Managing Large Liver Tumors: Strategies & Challenges

How is Y90 radioembolization rewriting the rules for managing large HCC tumors and creating new curative-intent...

1,200+ listens

Tumor Board

Tumor Board # 63

Jun 4, 2026

with Dr. Amy Luckenbaugh, Meredith Donahue NP, Dr. Bogdana Schmidt

Launching Co-Managed APP/MD Clinics for Bladder Cancer

Are traditional bladder cancer care models falling behind as new therapies flood the field and reshape the landscape?...

250+ listens

Urology

Urology # 313

Jun 30, 2026

with Dr. Kirsten Greene, Dr. Ruchika Talwar

Approaches to Pelvic Lymph Node Dissection in Contemporary Prostate Cancer Surgery

Is pelvic lymph node dissection still necessary in the era of PSMA PET imaging? In this episode of BackTable Urology,...

Urology

Urology # 310

Jun 18, 2026

with Dr. Sunil Patel, Dr. Kristen Scarpato, Dr. Bogdana Schmidt

Bladder Cancer Risk Stratification: Best Practices

Why does up to 10% of bladder cancer pathology change on expert review, and what does that mean for your intermediate...

780+ listens

VI

Vascular & IR # 653

Jun 9, 2026

with Dr. Beau Toskich, Dr. Christopher Malone, Dr. Venkatesh Krishnasamy

Radiation Lobectomy Techniques &  Downstaging for HCC

How can targeted liver radiation unlock surgical or transplant options for tough hepatocellular carcinoma (HCC) cases?...

1,300+ listens

Urology

Urology # 306

Jun 4, 2026

with Dr. Amy Luckenbaugh, Meredith Donahue NP, Dr. Bogdana Schmidt

Launching Co-Managed APP/MD Clinics for Bladder Cancer

Are traditional bladder cancer care models falling behind as new therapies flood the field and reshape the landscape?...

730+ listens

Tumor Board

Tumor Board Case

Oct 28, 2025

HNC: T2N3 Primary Low Volume Head & Neck Squamous Cell Carcinoma

with Dr. Dylan Roden, Dr. Ravindra Uppaluri and Dr. Adam Luginbuhl

Tumor Board

Tumor Board Case

Oct 28, 2025

HNC: T4N2bM0 High Volume Primary Locally Advanced Head & Neck Squamous Cell Carcinoma

with Dr. Dylan Roden, Dr. Ravindra Uppaluri and Dr. Adam Luginbuhl

ENT

ENT Case

Oct 28, 2025

HNC: T3N0 Anterior Larynx Cancer with Erosion of Thyroid Cartilage Inner Table

with Dr. Dylan Roden, Dr. Ravindra Uppaluri and Dr. Adam Luginbuhl

Tumor Board

Tumor Board Case

Oct 28, 2025

HNC: T3N0 Anterior Larynx Cancer with Erosion of Thyroid Cartilage Inner Table

with Dr. Dylan Roden, Dr. Ravindra Uppaluri and Dr. Adam Luginbuhl

ENT

ENT Case

Oct 28, 2025

HNC: T2N3 Primary Low Volume Head & Neck Squamous Cell Carcinoma

with Dr. Dylan Roden, Dr. Ravindra Uppaluri and Dr. Adam Luginbuhl

ENT

ENT Case

Oct 28, 2025

HNC: T4N2bM0 High Volume Primary Locally Advanced Head & Neck Squamous Cell Carcinoma

with Dr. Dylan Roden, Dr. Ravindra Uppaluri and Dr. Adam Luginbuhl

Multidisciplinary Approach to Non-Small Cell Lung Cancer

Tumor Board Course

2 CME/CE credits, 2.5 hours, 19 lessons

SuperCourse: Spine & Bone Tumor Ablation

VI Course

2.5 hours, 41 lessons

IR, Surgical & Transplant Collaboration for HCC

Tumor Board Course

2 hours, 22 lessons

Y90 Dosing & Ablation Modalities for HCC

Tumor Board Course

2 hours, 20 lessons

The Materials available on BackTable are provided for informational and educational purposes only and are not a substitute for the independent professional judgment of a qualified healthcare professional in diagnosing or treating patients. Any opinions, statements, or views expressed are those of the individual contributors and do not necessarily reflect those of the publisher, platform, or any affiliated organization.

bottom of page